SCHEMBL8502233

SCHEMBL8502233

CCCCc1c(N2CC(N3Cc4ccccc4C3=O)C2)ccc2c1C(C(=O)NCC(F)(F)F)c1ccccc1-2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MTR Q99707 1/20 0.31
▸ SCN1A P35498 3/20 0.31
▸ SCN5A Q14524 3/20 0.31
▸ SCN9A Q15858 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8664324 0.94 NPY1R (0.35) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8503703 0.94 PSEN1 (0.36) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8503792 0.93 POLB (0.33) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8485778 0.92 NPY1R (0.37) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8664248 0.88 PSEN1 (0.34) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8666699 0.87 NPY1R (0.33) GAANPSR1POLBLMNAMTR
SCHEMBL8487926 0.87 NPY1R (0.36) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8479608 0.85 NPY1R (0.36) GAANPSR1POLBPSEN1PSEN2
SCHEMBL8593680 0.83 POLB (0.42) NPSR1POLBPSEN1PSEN2APH1B
SCHEMBL8501237 0.80 MTTP (0.36) GAANPSR1POLBPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US disclosed
Send feedback